User profiles for "author:T. Oliver"

Tom Oliver

- Verified email at reading.ac.uk - Cited by 7990

Trudy G Oliver

- Verified email at duke.edu - Cited by 5771

Thomas Andrew Oliver

- Verified email at noaa.gov - Cited by 4500

Benefits and harms of CT screening for lung cancer: a systematic review

PB Bach, JN Mirkin, TK Oliver, CG Azzoli, DA Berry… - Jama, 2012 - jamanetwork.com
Context Lung cancer is the leading cause of cancer death. Most patients are diagnosed with
advanced disease, resulting in a very low 5-year survival. Screening may reduce the risk of …

Biodiversity and resilience of ecosystem functions

TH Oliver, MS Heard, NJB Isaac, DB Roy… - Trends in ecology & …, 2015 - cell.com
Accelerating rates of environmental change and the continued loss of global biodiversity
threaten functions and services delivered by ecosystems. Much ecosystem monitoring and …

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group …

…, GM Mead, R Mueller, C Nichols, N Nicolai, T Oliver… - European urology, 2008 - Elsevier
OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer
Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many …

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized …

…, JT Roberts, L Dogliotti, T Oliver… - Journal of clinical …, 2023 - ingentaconnect.com
PURPOSE: Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, and
cisplatin (MVAC) were compared in patients with locally advanced or metastatic transitional …

[PDF][PDF] Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with …

…, JT Roberts, S Ricci, L Dogliotti, T Oliver… - Journal of clinical …, 2005 - Citeseer
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With
Methotrexate, Vinblastine, Doxorubic Page 1 Long-Term Survival Results of a Randomized …

[HTML][HTML] European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

…, G Daugaard, PHM de Mulder, A Horwich, T Oliver… - Annals of …, 2004 - Elsevier
Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise
in the incidence every 20 years. Despite this, the high sensitivity of germ cell tumours to …

Genomic basis for coral resilience to climate change

DJ Barshis, JT Ladner, TA Oliver… - Proceedings of the …, 2013 - National Acad Sciences
Recent advances in DNA-sequencing technologies now allow for in-depth characterization
of the genomic stress responses of many organisms beyond model taxa. They are especially …

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

CM Rudin, JT Poirier, LA Byers, C Dive… - Nature Reviews …, 2019 - nature.com
Small cell lung cancer (SCLC) is an exceptionally lethal malignancy for which more effective
therapies are urgently needed. Several lines of evidence, from SCLC primary human …

Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review

JD Merker, GR Oxnard, C Compton… - … of pathology & …, 2018 - meridian.allenpress.com
Purpose.—Clinical use of analytical tests to assess genomic variants in circulating tumor
DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology …

Evaluating life‐history strategies of reef corals from species traits

ES Darling, L Alvarez‐Filip, TA Oliver… - Ecology …, 2012 - Wiley Online Library
Classifying the biological traits of organisms can test conceptual frameworks of life‐history
strategies and allow for predictions of how different species may respond to environmental …